New Zealand markets closed

Plus Therapeutics, Inc. (PSTV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8000+0.1000 (+5.88%)
At close: 03:59PM EST
1.7900 -0.01 (-0.56%)
After hours: 05:55PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 8.14M
Enterprise value 1.72M
Trailing P/E 0.50
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)20.71
Price/book (mrq)3.10
Enterprise value/revenue 7.67
Enterprise value/EBITDA -0.12

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 3-69.23%
S&P500 52-week change 314.90%
52-week high 37.2000
52-week low 30.9700
50-day moving average 31.4258
200-day moving average 32.8851

Share statistics

Avg vol (3-month) 3698.08k
Avg vol (10-day) 3149.06k
Shares outstanding 54.52M
Implied shares outstanding 64.52M
Float 84.46M
% held by insiders 10.50%
% held by institutions 15.30%
Shares short (14 Nov 2023) 4215.04k
Short ratio (14 Nov 2023) 40.3
Short % of float (14 Nov 2023) 44.76%
Short % of shares outstanding (14 Nov 2023) 44.75%
Shares short (prior month 12 Oct 2023) 470.64k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Aug 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 330 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)-262.18%

Management effectiveness

Return on assets (ttm)-51.65%
Return on equity (ttm)-216.23%

Income statement

Revenue (ttm)3.75M
Revenue per share (ttm)1.46
Quarterly revenue growth (yoy)1,598.60%
Gross profit (ttm)-9.47M
Net income avi to common (ttm)-15.16M
Diluted EPS (ttm)-5.8700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.01M
Total cash per share (mrq)2.43
Total debt (mrq)4.58M
Total debt/equity (mrq)174.79%
Current ratio (mrq)1.10
Book value per share (mrq)0.58

Cash flow statement

Operating cash flow (ttm)-13.2M
Levered free cash flow (ttm)-7.88M